Clinical Trial Update: Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis

View source ↗

Summary

This clinical trial update assesses labile plasma iron (LPI) in patients with myelodysplastic syndromes and primary myelofibrosis; the current status of the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myelofibrosis

Snippet

Sponsor: Wolfson Medical Center | Conditions: Myelodysplastic Syndrome, Primary Myelofibrosis | Status: UNKNOWN